MSX2, msh homeobox 2, 4488

N. diseases: 135; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0740302
Disease: 5q-syndrome
5q-syndrome
0.010 Biomarker disease BEFREE Our study confirms that early fusion of cranial sutures commonly observed in the dup(5q) syndrome is caused by triplication of the MSX2 gene and strongly supports the crucial role of this gene in the development of craniofacial structures. 18000908 2007
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.010 Biomarker phenotype BEFREE Above all, our results revealed that deletion of homeoproteins Msx1 and Msx2 could lead to behavioral disorders and suggested that Msx1 and Msx2 played a crucial role in regulating the development and function of the neocortex. 31221479 2019
CUI: C0000846
Disease: Agenesis
Agenesis
0.010 Biomarker disease BEFREE We postulate that a terminal distal trisomy of 5q35.2-5q35.3, which maps 1.1 Mb telomeric to the MSX2 gene is causative for both radial agenesis and complex heart defect in our proband. 23342975 2013
CUI: C0002452
Disease: Amelogenesis Imperfecta
Amelogenesis Imperfecta
0.010 AlteredExpression disease BEFREE Since mouse null mutant of homeobox transcription factor, Msx2, exhibits a phenotype resembling AI, the human homolog of this gene, MSX2, was sequenced. 16420275 2006
Amputated structure (morphologic abnormality)
0.010 Biomarker phenotype BEFREE We transduced mBMSCs with <i>Msx1</i> and <i>Msx2</i> genes and compared osteogenic activity and expression levels of several <i>Msx</i>-regulated genes (<i>Bmp4</i>, <i>Fgf8</i>, and keratin 14 (<i>K14</i>)) in BlC groups, including MSX1, MSX2, and MSX1/2 (in a 1:1 ratio) with those in mBMSCs and BCs <i>in vitro</i> and <i>in vivo</i> following injection into the amputation site. 28461333 2017
CUI: C0002902
Disease: Anencephaly
Anencephaly
0.010 Biomarker disease BEFREE A single-strand conformation analysis (SSCA) mutation screen of the coding sequences of TFAP2alpha and MSX2 was performed for 204 nonsyndromic NTD patients including cases of anencephaly (n = 10), encephalocele (n = 8), and spina bifida aperta, SBA (n = 183). 11320527 2001
CUI: C0038013
Disease: Ankylosing spondylitis
Ankylosing spondylitis
0.010 GeneticVariation disease BEFREE Association of the MSX2 gene polymorphisms with ankylosing spondylitis in Japanese. 18299954 2008
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.010 AlteredExpression disease BEFREE The sensitivity, specificity, and diagnostic accuracy for PDAC of cytology and MSX2 expression in ductal strictures were: 47.4%, 100%, and 63.4%, and 73.7%, 84.0%, and 79.3%, respectively. 20961362 2011
CUI: C3495676
Disease: Anorectal Malformations
Anorectal Malformations
0.010 AlteredExpression group BEFREE Immunohistochemical staining of ARM embryos revealed that MSX2 was mainly expressed in the epithelium of the hindgut and urorectal septum (URS) on GD14. 30268882 2018
CUI: C1855698
Disease: Aplasia cutis congenita of scalp
Aplasia cutis congenita of scalp
0.100 Biomarker disease HPO
CUI: C4021084
Disease: Aplasia of optic nerve
Aplasia of optic nerve
0.010 AlteredExpression phenotype BEFREE Indeed, overexpression of the Msx2 gene in a mouse model resulted also in optic nerve aplasia and microphthalmia. 24666290 2015
CUI: C1862389
Disease: ATRIAL SEPTAL DEFECT 1
ATRIAL SEPTAL DEFECT 1
0.010 Biomarker disease BEFREE In this study, we used Msx2 conditional knockout (CKO) mice as a model and found that Msx2 deficiency in surface ectoderm induced ASD. 30683901 2019
CUI: C0018817
Disease: Atrial Septal Defects
Atrial Septal Defects
0.010 Biomarker group BEFREE In this study, we used Msx2 conditional knockout (CKO) mice as a model and found that Msx2 deficiency in surface ectoderm induced ASD. 30683901 2019
CUI: C1510586
Disease: Autism Spectrum Disorders
Autism Spectrum Disorders
0.010 Biomarker disease BEFREE In this study, we used Msx2 conditional knockout (CKO) mice as a model and found that Msx2 deficiency in surface ectoderm induced ASD. 30683901 2019
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.010 Biomarker group BEFREE This study aimed to determine Msh homeobox 2 (MSX2) and B cell lymphoma-2 (BCL2) expression patterns during anorectal development in anorectal malformations (ARM) and normal rat embryos, with the goals of determining the role of MSX2 and BCL2 in ARM pathogenesis. 30268882 2018
CUI: C0004930
Disease: Behavior Disorders
Behavior Disorders
0.010 Biomarker group BEFREE Above all, our results revealed that deletion of homeoproteins Msx1 and Msx2 could lead to behavioral disorders and suggested that Msx1 and Msx2 played a crucial role in regulating the development and function of the neocortex. 31221479 2019
CUI: C4021164
Disease: Bicoronal synostosis
Bicoronal synostosis
0.100 Biomarker disease HPO
CUI: C1857484
Disease: Brachyturricephaly
Brachyturricephaly
0.100 Biomarker phenotype HPO
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 Biomarker disease BEFREE Moreover, immunohistochemistry of human infiltrating breast carcinomas showed positive staining for Msx2 only in the infiltrating tumor cells while the non-infiltrating tumor cells were negative. 19170109 2009
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 AlteredExpression disease BEFREE Examination of Msx2 mRNA expression in a breast cancer transcriptomic dataset demonstrated that increased levels of Msx2 were associated with good prognosis (P = 0.011). 20682066 2010
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 AlteredExpression disease BEFREE The aim of this study was to compare expression of Msx2 gene in breast cancer of different genotypes as well as in surrounding nonmalignant tissues. 15945508 2005
CUI: C4025787
Disease: Calvarial skull defect
Calvarial skull defect
0.010 GeneticVariation disease BEFREE Sequence analysis further showed that in four out of five families an MSX2 mutation was responsible for the skull defect. 10767351 2000
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.030 Biomarker phenotype BEFREE Msx2 is a homeobox gene implicated in organ development, bone metabolism, and tumorigenesis. 18187185 2008
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.030 AlteredExpression phenotype BEFREE Overexpression of Msx1 and Msx2 may also be involved in tumorigenesis. 15300013 2004
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.030 AlteredExpression phenotype BEFREE Tumorigenesis led to about a twofold decrease in the relative amount of Msx2 mRNA except for ER+/PR+ immunophenotype, where no changes were observed. 15945508 2005